

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85469896 |
| 2 | desmosome organization (GO:0002934) | 3.66014095 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 3.45495340 |
| 4 | hemidesmosome assembly (GO:0031581) | 3.38075960 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 3.37623993 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28583139 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28583139 |
| 8 | membrane raft organization (GO:0031579) | 3.25292544 |
| 9 | negative regulation of phagocytosis (GO:0050765) | 3.22807132 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20242662 |
| 11 | skin morphogenesis (GO:0043589) | 3.15330853 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12053514 |
| 13 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.06662141 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.05956874 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05392686 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 2.98484135 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98484135 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 2.98484135 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98484135 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98484135 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98484135 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93419824 |
| 23 | hepatocyte apoptotic process (GO:0097284) | 2.91528895 |
| 24 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.90982715 |
| 25 | response to peptidoglycan (GO:0032494) | 2.90492761 |
| 26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88342920 |
| 27 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.87992073 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 2.87451215 |
| 29 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.87106777 |
| 30 | pinocytosis (GO:0006907) | 2.85395222 |
| 31 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.82619462 |
| 32 | negative regulation of granulocyte differentiation (GO:0030853) | 2.82363408 |
| 33 | decidualization (GO:0046697) | 2.77968484 |
| 34 | regulation of vitamin metabolic process (GO:0030656) | 2.74844359 |
| 35 | regulation of metalloenzyme activity (GO:0048552) | 2.74454937 |
| 36 | positive regulation of extracellular matrix organization (GO:1903055) | 2.71234113 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70925308 |
| 38 | reactive oxygen species biosynthetic process (GO:1903409) | 2.70895916 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 2.70727614 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 2.69399082 |
| 41 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67896760 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 2.65201711 |
| 43 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.64306208 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60776712 |
| 45 | neutrophil activation (GO:0042119) | 2.60560616 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60258295 |
| 47 | protein localization to endosome (GO:0036010) | 2.59962076 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.59472718 |
| 49 | leukocyte aggregation (GO:0070486) | 2.58871222 |
| 50 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58407885 |
| 51 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56290985 |
| 52 | positive regulation of p38MAPK cascade (GO:1900745) | 2.55562978 |
| 53 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.54369038 |
| 54 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.52849117 |
| 55 | definitive hemopoiesis (GO:0060216) | 2.51622388 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 2.50938363 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 2.50938363 |
| 58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.48370406 |
| 59 | positive regulation of macrophage differentiation (GO:0045651) | 2.45489745 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 2.45344292 |
| 61 | * regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.42724539 |
| 62 | cellular response to zinc ion (GO:0071294) | 2.41906443 |
| 63 | positive regulation of interferon-beta production (GO:0032728) | 2.41035293 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39781209 |
| 65 | granulocyte activation (GO:0036230) | 2.38567599 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37495828 |
| 67 | endodermal cell differentiation (GO:0035987) | 2.37127079 |
| 68 | regulation of chemokine biosynthetic process (GO:0045073) | 2.35955107 |
| 69 | response to fungus (GO:0009620) | 2.35158760 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34964269 |
| 71 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.34786406 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.34324962 |
| 73 | response to interferon-alpha (GO:0035455) | 2.32662299 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.32406234 |
| 75 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.32236860 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.30979083 |
| 77 | sphingosine metabolic process (GO:0006670) | 2.30909809 |
| 78 | NIK/NF-kappaB signaling (GO:0038061) | 2.29926990 |
| 79 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.29882550 |
| 80 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.29428130 |
| 81 | respiratory burst (GO:0045730) | 2.28747025 |
| 82 | response to type I interferon (GO:0034340) | 2.28338787 |
| 83 | response to interferon-beta (GO:0035456) | 2.28304091 |
| 84 | keratan sulfate catabolic process (GO:0042340) | 2.27928635 |
| 85 | peptide catabolic process (GO:0043171) | 2.27815701 |
| 86 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.27706003 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 2.27205347 |
| 88 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.27136842 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.25949900 |
| 90 | regulation of B cell differentiation (GO:0045577) | 2.25830658 |
| 91 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.24478828 |
| 92 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.24210916 |
| 93 | negative regulation of protein autophosphorylation (GO:0031953) | 2.24084242 |
| 94 | negative regulation of lipid storage (GO:0010888) | 2.23630228 |
| 95 | wound healing, spreading of epidermal cells (GO:0035313) | 2.23495688 |
| 96 | type I interferon signaling pathway (GO:0060337) | 2.23253067 |
| 97 | cellular response to type I interferon (GO:0071357) | 2.23253067 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.22068860 |
| 99 | superoxide anion generation (GO:0042554) | 2.21899403 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21827338 |
| 101 | response to host immune response (GO:0052572) | 2.21827338 |
| 102 | dendritic cell chemotaxis (GO:0002407) | 2.21154712 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 2.20931378 |
| 104 | interferon-gamma secretion (GO:0072643) | 2.20416142 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.19182810 |
| 106 | regulation of interleukin-8 secretion (GO:2000482) | 2.19182134 |
| 107 | iron ion import (GO:0097286) | 2.18381901 |
| 108 | embryonic process involved in female pregnancy (GO:0060136) | 2.17291482 |
| 109 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.16956402 |
| 110 | response to laminar fluid shear stress (GO:0034616) | 2.16805561 |
| 111 | substrate-dependent cell migration (GO:0006929) | 2.16473610 |
| 112 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.16348039 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.16049403 |
| 114 | regulation of macrophage cytokine production (GO:0010935) | 2.15327897 |
| 115 | hyaluronan catabolic process (GO:0030214) | 2.15114893 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.14962375 |
| 117 | cellular extravasation (GO:0045123) | 2.14666035 |
| 118 | response to host (GO:0075136) | 2.14550128 |
| 119 | response to host defenses (GO:0052200) | 2.14550128 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.14550128 |
| 121 | regulation of mononuclear cell migration (GO:0071675) | 2.14532102 |
| 122 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.14241675 |
| 123 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.12697079 |
| 124 | regulation of chemokine secretion (GO:0090196) | 2.12505667 |
| 125 | actin nucleation (GO:0045010) | 2.12502692 |
| 126 | B cell mediated immunity (GO:0019724) | 2.11841891 |
| 127 | dendritic cell migration (GO:0036336) | 2.11741238 |
| 128 | detection of external biotic stimulus (GO:0098581) | 2.11215141 |
| 129 | positive regulation of chemokine secretion (GO:0090197) | 2.11069852 |
| 130 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.10929656 |
| 131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.10253856 |
| 132 | regulation of extracellular matrix disassembly (GO:0010715) | 2.10155855 |
| 133 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.10118396 |
| 134 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.09615257 |
| 135 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.09577673 |
| 136 | ER overload response (GO:0006983) | 2.09100376 |
| 137 | positive regulation of T cell chemotaxis (GO:0010820) | 2.09016152 |
| 138 | regulation of T cell chemotaxis (GO:0010819) | 2.09016152 |
| 139 | diol metabolic process (GO:0034311) | 2.08333750 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.07802711 |
| 141 | establishment of endothelial barrier (GO:0061028) | 2.07781654 |
| 142 | surfactant homeostasis (GO:0043129) | 2.07404496 |
| 143 | defense response to fungus (GO:0050832) | 2.07055130 |
| 144 | myeloid dendritic cell activation (GO:0001773) | 2.06798975 |
| 145 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.06752015 |
| 146 | regulation of podosome assembly (GO:0071801) | 2.06514483 |
| 147 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.06248443 |
| 148 | cellular response to interferon-alpha (GO:0035457) | 2.05879975 |
| 149 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.05711386 |
| 150 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.05462531 |
| 151 | leukocyte cell-cell adhesion (GO:0007159) | 2.05200883 |
| 152 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.05170148 |
| 153 | regulation of growth of symbiont in host (GO:0044126) | 2.05170148 |
| 154 | negative regulation of growth of symbiont in host (GO:0044130) | 2.05170148 |
| 155 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.05170148 |
| 156 | regulation of superoxide anion generation (GO:0032928) | 2.05043974 |
| 157 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.04278153 |
| 158 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.04138565 |
| 159 | T-helper 1 type immune response (GO:0042088) | 2.02660941 |
| 160 | response to vitamin D (GO:0033280) | 2.01041876 |
| 161 | type B pancreatic cell proliferation (GO:0044342) | 2.00900964 |
| 162 | negative regulation of fibrinolysis (GO:0051918) | 2.00855524 |
| 163 | adhesion of symbiont to host (GO:0044406) | 2.00671116 |
| 164 | negative regulation of viral entry into host cell (GO:0046597) | 2.00360025 |
| 165 | response to progesterone (GO:0032570) | 2.00174759 |
| 166 | negative regulation of complement activation (GO:0045916) | 1.99141218 |
| 167 | sphingoid metabolic process (GO:0046519) | 1.98391416 |
| 168 | positive regulation of chemokine production (GO:0032722) | 1.97593275 |
| 169 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 1.97190302 |
| 170 | negative regulation of protein activation cascade (GO:2000258) | 1.96301685 |
| 171 | cell-substrate junction assembly (GO:0007044) | 1.95956188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.15057707 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06699027 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.73649287 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73470932 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40866336 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25362115 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19417536 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.17469712 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02311587 |
| 10 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.61964889 |
| 11 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54496717 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52514186 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52268575 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41941833 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41867017 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.36989519 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36771000 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35760772 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30343010 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.27056084 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22959684 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19237774 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.18940823 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17881770 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15879581 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01965569 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96517471 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93133447 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.89959441 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89411198 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88090611 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88061232 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85607553 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85564874 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.78879442 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.69719455 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68016375 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66555886 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66488815 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65766603 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.61799050 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60755526 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60142787 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59443108 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.57415703 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55802667 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54389443 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53560682 |
| 49 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52304908 |
| 50 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51863599 |
| 51 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.51202332 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51085228 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44818079 |
| 54 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44708284 |
| 55 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43651174 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43252559 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42525758 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40500156 |
| 59 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39187110 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35814384 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35595630 |
| 62 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34663731 |
| 63 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34663731 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34554695 |
| 65 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34114673 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31379401 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30931176 |
| 68 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30202868 |
| 69 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29141402 |
| 70 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.28513212 |
| 71 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.27399619 |
| 72 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26619052 |
| 73 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24720026 |
| 74 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23618710 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23329413 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22568117 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21797835 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21545166 |
| 79 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17207215 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17096213 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16560409 |
| 82 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15499898 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13934071 |
| 84 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11604440 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11266140 |
| 86 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10809214 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09791716 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08877450 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08770776 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08130736 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06792846 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06736269 |
| 93 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.06463023 |
| 94 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06327535 |
| 95 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05247083 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05180048 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03805370 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03122684 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02978758 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02612615 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02105264 |
| 102 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01938257 |
| 103 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01912492 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01481544 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00191850 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.00124644 |
| 107 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99972816 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99671601 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99352647 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99056244 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97776557 |
| 112 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96905053 |
| 113 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96829476 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96760268 |
| 115 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95370483 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95041725 |
| 117 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94035150 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93538551 |
| 119 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.93339577 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92697797 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92622732 |
| 122 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92330666 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92267573 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91323800 |
| 125 | * MAF_26560356_Chip-Seq_TH2_Human | 0.90040435 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89961738 |
| 127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89961738 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89773208 |
| 129 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.89552540 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88984680 |
| 131 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.88843343 |
| 132 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88830614 |
| 133 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87540688 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87268412 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86120671 |
| 136 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85343583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.32289517 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.59098483 |
| 3 | MP0003436_decreased_susceptibility_to | 2.52566854 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.35273162 |
| 5 | MP0005275_abnormal_skin_tensile | 2.30097092 |
| 6 | MP0006054_spinal_hemorrhage | 2.22655015 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.14259252 |
| 8 | MP0009785_altered_susceptibility_to | 2.04923190 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.00861241 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 1.95244713 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 1.94461925 |
| 12 | MP0003566_abnormal_cell_adhesion | 1.93055443 |
| 13 | * MP0002148_abnormal_hypersensitivity_rea | 1.87929364 |
| 14 | MP0003279_aneurysm | 1.86793376 |
| 15 | * MP0002419_abnormal_innate_immunity | 1.83644300 |
| 16 | MP0002396_abnormal_hematopoietic_system | 1.82201807 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.78516508 |
| 18 | MP0003724_increased_susceptibility_to | 1.76856957 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 1.76280923 |
| 20 | MP0005025_abnormal_response_to | 1.70579014 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.70001336 |
| 22 | MP0005503_abnormal_tendon_morphology | 1.69897097 |
| 23 | MP0002006_tumorigenesis | 1.65551509 |
| 24 | MP0000685_abnormal_immune_system | 1.65538398 |
| 25 | MP0003303_peritoneal_inflammation | 1.64820088 |
| 26 | * MP0002452_abnormal_antigen_presenting | 1.63760738 |
| 27 | MP0001790_abnormal_immune_system | 1.59051883 |
| 28 | MP0005387_immune_system_phenotype | 1.59051883 |
| 29 | MP0001800_abnormal_humoral_immune | 1.56381162 |
| 30 | MP0008004_abnormal_stomach_pH | 1.55991766 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.54187243 |
| 32 | MP0005671_abnormal_response_to | 1.53210808 |
| 33 | * MP0005023_abnormal_wound_healing | 1.51065773 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.51023732 |
| 35 | MP0003195_calcinosis | 1.50755472 |
| 36 | MP0002405_respiratory_system_inflammati | 1.47232991 |
| 37 | * MP0001881_abnormal_mammary_gland | 1.47069859 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.43957170 |
| 39 | MP0000858_altered_metastatic_potential | 1.43822659 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.43299916 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.42898014 |
| 42 | * MP0002420_abnormal_adaptive_immunity | 1.42894255 |
| 43 | MP0000343_altered_response_to | 1.42640501 |
| 44 | * MP0001819_abnormal_immune_cell | 1.42038408 |
| 45 | MP0002009_preneoplasia | 1.40778633 |
| 46 | MP0002723_abnormal_immune_serum | 1.39663868 |
| 47 | MP0005360_urolithiasis | 1.39088523 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.39086558 |
| 49 | MP0003448_altered_tumor_morphology | 1.37549305 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.36340871 |
| 51 | MP0001958_emphysema | 1.35469501 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.35421809 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.35421809 |
| 54 | MP0002060_abnormal_skin_morphology | 1.31954951 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.30441980 |
| 56 | MP0006082_CNS_inflammation | 1.27840845 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.27700781 |
| 58 | MP0003828_pulmonary_edema | 1.26523811 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.26037514 |
| 60 | * MP0001845_abnormal_inflammatory_respons | 1.24544661 |
| 61 | MP0003075_altered_response_to | 1.21504132 |
| 62 | MP0004947_skin_inflammation | 1.21402036 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.21351855 |
| 64 | MP0001853_heart_inflammation | 1.20341581 |
| 65 | MP0005451_abnormal_body_composition | 1.17261245 |
| 66 | * MP0002398_abnormal_bone_marrow | 1.15723574 |
| 67 | * MP0001216_abnormal_epidermal_layer | 1.14687026 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.13938406 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.13564630 |
| 70 | MP0005165_increased_susceptibility_to | 1.12194510 |
| 71 | MP0005390_skeleton_phenotype | 1.11174560 |
| 72 | * MP0000716_abnormal_immune_system | 1.10786901 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.10443466 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.10370254 |
| 75 | MP0002933_joint_inflammation | 1.10075853 |
| 76 | MP0009278_abnormal_bone_marrow | 1.09635584 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 1.08650567 |
| 78 | MP0002132_abnormal_respiratory_system | 1.08478386 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.08242457 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.07605039 |
| 81 | * MP0000689_abnormal_spleen_morphology | 1.07514908 |
| 82 | MP0005166_decreased_susceptibility_to | 1.07494972 |
| 83 | MP0001873_stomach_inflammation | 1.07095510 |
| 84 | * MP0000490_abnormal_crypts_of | 1.05874542 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 1.03826102 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 1.02684400 |
| 87 | * MP0002722_abnormal_immune_system | 1.02230177 |
| 88 | MP0002796_impaired_skin_barrier | 1.01880583 |
| 89 | MP0010678_abnormal_skin_adnexa | 1.01309232 |
| 90 | MP0003186_abnormal_redox_activity | 1.00956924 |
| 91 | MP0008469_abnormal_protein_level | 0.99967029 |
| 92 | * MP0002429_abnormal_blood_cell | 0.98812043 |
| 93 | MP0009764_decreased_sensitivity_to | 0.96910268 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.96895126 |
| 95 | MP0002168_other_aberrant_phenotype | 0.94987593 |
| 96 | MP0005083_abnormal_biliary_tract | 0.94506995 |
| 97 | MP0003941_abnormal_skin_development | 0.94504061 |
| 98 | MP0004272_abnormal_basement_membrane | 0.93848007 |
| 99 | MP0009840_abnormal_foam_cell | 0.93579291 |
| 100 | MP0003045_fibrosis | 0.92564717 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.90141857 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.89858665 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.89520299 |
| 104 | MP0001243_abnormal_dermal_layer | 0.87376303 |
| 105 | MP0010307_abnormal_tumor_latency | 0.86338519 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.86007655 |
| 107 | MP0001542_abnormal_bone_strength | 0.84980191 |
| 108 | MP0000249_abnormal_blood_vessel | 0.82485614 |
| 109 | MP0003795_abnormal_bone_structure | 0.81518396 |
| 110 | MP0001915_intracranial_hemorrhage | 0.81108713 |
| 111 | MP0003091_abnormal_cell_migration | 0.80466052 |
| 112 | MP0005164_abnormal_response_to | 0.79119595 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.78083776 |
| 114 | MP0004510_myositis | 0.77346604 |
| 115 | MP0004233_abnormal_muscle_weight | 0.77008053 |
| 116 | * MP0000627_abnormal_mammary_gland | 0.76840276 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.76303611 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.75345048 |
| 119 | MP0009763_increased_sensitivity_to | 0.73202380 |
| 120 | MP0002254_reproductive_system_inflammat | 0.73012201 |
| 121 | MP0001851_eye_inflammation | 0.72821137 |
| 122 | MP0009053_abnormal_anal_canal | 0.71378906 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.70084859 |
| 124 | MP0005508_abnormal_skeleton_morphology | 0.69972080 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69639846 |
| 126 | MP0004883_abnormal_blood_vessel | 0.67893914 |
| 127 | MP0002138_abnormal_hepatobiliary_system | 0.67542220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.97772660 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 3.88936709 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.88936709 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.88936709 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.67993598 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.26281374 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.15033858 |
| 8 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.13450406 |
| 9 | Osteolytic defects of the hand bones (HP:0009699) | 3.13450406 |
| 10 | Myositis (HP:0100614) | 3.09580811 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.06278282 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.02729474 |
| 13 | Vascular calcification (HP:0004934) | 2.91189082 |
| 14 | Vascular tortuosity (HP:0004948) | 2.90264259 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85425047 |
| 16 | Mucopolysacchariduria (HP:0008155) | 2.85425047 |
| 17 | Arterial tortuosity (HP:0005116) | 2.85077432 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79764329 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79764329 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79764329 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 2.78155276 |
| 22 | Premature rupture of membranes (HP:0001788) | 2.77123048 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76307239 |
| 24 | Orchitis (HP:0100796) | 2.75420357 |
| 25 | Spinal cord lesions (HP:0100561) | 2.74892085 |
| 26 | Syringomyelia (HP:0003396) | 2.74892085 |
| 27 | Pustule (HP:0200039) | 2.74655570 |
| 28 | Aortic dissection (HP:0002647) | 2.71384524 |
| 29 | Aortic aneurysm (HP:0004942) | 2.63102866 |
| 30 | Periodontitis (HP:0000704) | 2.61997672 |
| 31 | Cellulitis (HP:0100658) | 2.59724724 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.54034472 |
| 33 | Cervical subluxation (HP:0003308) | 2.49108147 |
| 34 | Myocardial infarction (HP:0001658) | 2.48072523 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.46541918 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.45644818 |
| 37 | Alopecia of scalp (HP:0002293) | 2.43586699 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.41940701 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.40747794 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.38254365 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 2.37450661 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.35019510 |
| 43 | Recurrent viral infections (HP:0004429) | 2.29990439 |
| 44 | Milia (HP:0001056) | 2.28054433 |
| 45 | Thrombocytosis (HP:0001894) | 2.27944635 |
| 46 | Ovoid vertebral bodies (HP:0003300) | 2.27600984 |
| 47 | Amyloidosis (HP:0011034) | 2.26866436 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.25596204 |
| 49 | Gingivitis (HP:0000230) | 2.25189135 |
| 50 | Atrophic scars (HP:0001075) | 2.24382951 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.23517296 |
| 52 | Optic neuritis (HP:0100653) | 2.23517296 |
| 53 | Hematochezia (HP:0002573) | 2.22777968 |
| 54 | Onycholysis (HP:0001806) | 2.21562964 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.21519003 |
| 56 | Nonimmune hydrops fetalis (HP:0001790) | 2.20723360 |
| 57 | Petechiae (HP:0000967) | 2.19000382 |
| 58 | Glomerulonephritis (HP:0000099) | 2.18060593 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.16810243 |
| 60 | Peritonitis (HP:0002586) | 2.16555639 |
| 61 | Abnormal platelet volume (HP:0011876) | 2.16152287 |
| 62 | Osteomyelitis (HP:0002754) | 2.15630322 |
| 63 | Arterial thrombosis (HP:0004420) | 2.14502979 |
| 64 | Nephritis (HP:0000123) | 2.14249139 |
| 65 | Nuclear cataract (HP:0100018) | 2.10829125 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06510838 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.06323123 |
| 68 | Plantar hyperkeratosis (HP:0007556) | 2.05579875 |
| 69 | Axonal loss (HP:0003447) | 2.03372534 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.02280556 |
| 71 | IgM deficiency (HP:0002850) | 2.01938117 |
| 72 | Asymmetry of the thorax (HP:0001555) | 2.01937975 |
| 73 | Hypoplasia of the odontoid process (HP:0003311) | 1.99532979 |
| 74 | Malnutrition (HP:0004395) | 1.99032751 |
| 75 | Recurrent skin infections (HP:0001581) | 1.97468238 |
| 76 | Increased mean platelet volume (HP:0011877) | 1.96852050 |
| 77 | Abnormality of complement system (HP:0005339) | 1.96795964 |
| 78 | Dilatation of the ascending aorta (HP:0005111) | 1.96761530 |
| 79 | Ankle contracture (HP:0006466) | 1.96221517 |
| 80 | Eosinophilia (HP:0001880) | 1.92504740 |
| 81 | Meningitis (HP:0001287) | 1.91813611 |
| 82 | Skin ulcer (HP:0200042) | 1.90924271 |
| 83 | Abnormal platelet function (HP:0011869) | 1.88893675 |
| 84 | Impaired platelet aggregation (HP:0003540) | 1.88893675 |
| 85 | Flared iliac wings (HP:0002869) | 1.88257504 |
| 86 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.88251267 |
| 87 | Natal tooth (HP:0000695) | 1.87659147 |
| 88 | Pulmonary artery stenosis (HP:0004415) | 1.87342587 |
| 89 | Abnormality of the odontoid process (HP:0003310) | 1.86842041 |
| 90 | Joint stiffness (HP:0001387) | 1.86568230 |
| 91 | Nail dystrophy (HP:0008404) | 1.85750136 |
| 92 | Increased serum ferritin (HP:0003281) | 1.84746665 |
| 93 | Epistaxis (HP:0000421) | 1.83195239 |
| 94 | Elbow flexion contracture (HP:0002987) | 1.83160297 |
| 95 | Loss of speech (HP:0002371) | 1.82756401 |
| 96 | Spondylolisthesis (HP:0003302) | 1.82677823 |
| 97 | Complement deficiency (HP:0004431) | 1.82575345 |
| 98 | Increased connective tissue (HP:0009025) | 1.82432824 |
| 99 | Leukocytosis (HP:0001974) | 1.81847847 |
| 100 | Emphysema (HP:0002097) | 1.81717783 |
| 101 | Granulocytopenia (HP:0001913) | 1.81132927 |
| 102 | Femoral bowing (HP:0002980) | 1.80744254 |
| 103 | Gingival bleeding (HP:0000225) | 1.80479297 |
| 104 | Abnormality of carpal bone ossification (HP:0006257) | 1.80104138 |
| 105 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.79991376 |
| 106 | Aneurysm (HP:0002617) | 1.79193319 |
| 107 | Blue sclerae (HP:0000592) | 1.78838195 |
| 108 | Vasculitis (HP:0002633) | 1.78486197 |
| 109 | Flat acetabular roof (HP:0003180) | 1.77634936 |
| 110 | Obstructive lung disease (HP:0006536) | 1.77213500 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77213500 |
| 112 | Abnormality of the acetabulum (HP:0003170) | 1.75669217 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.75622886 |
| 114 | Thin bony cortex (HP:0002753) | 1.75088120 |
| 115 | Soft skin (HP:0000977) | 1.74167392 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.73489422 |
| 117 | Hypoplasia of dental enamel (HP:0006297) | 1.72578078 |
| 118 | Fragile skin (HP:0001030) | 1.71233362 |
| 119 | Short nail (HP:0001799) | 1.70513433 |
| 120 | Tibial bowing (HP:0002982) | 1.69114695 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 1.68710611 |
| 122 | Lip pit (HP:0100267) | 1.67745212 |
| 123 | Biconcave vertebral bodies (HP:0004586) | 1.67702560 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.66838098 |
| 125 | Follicular hyperkeratosis (HP:0007502) | 1.66554211 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.66067721 |
| 127 | Thick nail (HP:0001805) | 1.65563550 |
| 128 | Coxa vara (HP:0002812) | 1.65308854 |
| 129 | Chronic diarrhea (HP:0002028) | 1.65159652 |
| 130 | Mitral stenosis (HP:0001718) | 1.64583483 |
| 131 | Fragile nails (HP:0001808) | 1.64549451 |
| 132 | Aortic regurgitation (HP:0001659) | 1.64342732 |
| 133 | Sparse eyelashes (HP:0000653) | 1.63337804 |
| 134 | Recurrent bronchitis (HP:0002837) | 1.62957586 |
| 135 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62741057 |
| 136 | Glucose intolerance (HP:0000833) | 1.61705465 |
| 137 | Cardiovascular calcification (HP:0011915) | 1.61604571 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.61501272 |
| 139 | Chronic otitis media (HP:0000389) | 1.61498641 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.61074786 |
| 141 | Abnormality of T cell number (HP:0011839) | 1.60959125 |
| 142 | Abnormality of nail color (HP:0100643) | 1.60887224 |
| 143 | Wormian bones (HP:0002645) | 1.60491454 |
| 144 | Popliteal pterygium (HP:0009756) | 1.60089168 |
| 145 | Abnormality of T cells (HP:0002843) | 1.59677748 |
| 146 | Abnormal foot bone ossification (HP:0010675) | 1.59123144 |
| 147 | Abnormality of the common coagulation pathway (HP:0010990) | 1.58782739 |
| 148 | J-shaped sella turcica (HP:0002680) | 1.57429486 |
| 149 | Hemoptysis (HP:0002105) | 1.57167461 |
| 150 | Basal ganglia calcification (HP:0002135) | 1.56819943 |
| 151 | Urticaria (HP:0001025) | 1.56107904 |
| 152 | Increased cerebral lipofuscin (HP:0011813) | 1.55959131 |
| 153 | Bone cyst (HP:0012062) | 1.55638022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 2.82730249 |
| 2 | TGFBR2 | 2.60439959 |
| 3 | ERN1 | 2.41587186 |
| 4 | MAP4K1 | 2.19177786 |
| 5 | TYK2 | 2.07883428 |
| 6 | PKN2 | 2.03582434 |
| 7 | JAK3 | 2.00521780 |
| 8 | IRAK4 | 1.97777080 |
| 9 | STK10 | 1.97413476 |
| 10 | TRPM7 | 1.96942611 |
| 11 | NEK9 | 1.94005821 |
| 12 | SIK3 | 1.88450427 |
| 13 | MAP3K12 | 1.86662354 |
| 14 | DDR2 | 1.84720278 |
| 15 | NME2 | 1.81754386 |
| 16 | IRAK3 | 1.76096743 |
| 17 | PIM2 | 1.75078829 |
| 18 | TBK1 | 1.72634755 |
| 19 | MAP2K3 | 1.71038779 |
| 20 | ZAP70 | 1.67250281 |
| 21 | TRIB3 | 1.63611914 |
| 22 | PIM1 | 1.56731617 |
| 23 | IKBKE | 1.56132965 |
| 24 | MAP3K3 | 1.55265452 |
| 25 | IKBKB | 1.49294995 |
| 26 | MET | 1.47969460 |
| 27 | TXK | 1.47712998 |
| 28 | PTK2 | 1.47329114 |
| 29 | BLK | 1.43903585 |
| 30 | MAP3K13 | 1.43601608 |
| 31 | KIT | 1.42783821 |
| 32 | ZAK | 1.42425602 |
| 33 | RPS6KA4 | 1.42331589 |
| 34 | LRRK2 | 1.42196798 |
| 35 | JAK1 | 1.37910431 |
| 36 | FGFR3 | 1.36579928 |
| 37 | TTN | 1.36484784 |
| 38 | PRKD2 | 1.32114342 |
| 39 | BMPR2 | 1.32083077 |
| 40 | EEF2K | 1.31067546 |
| 41 | PRPF4B | 1.28171298 |
| 42 | BTK | 1.27646261 |
| 43 | TEC | 1.27053423 |
| 44 | EPHA3 | 1.26960763 |
| 45 | ARAF | 1.25473476 |
| 46 | STK24 | 1.22143656 |
| 47 | CHUK | 1.21895589 |
| 48 | SIK1 | 1.21222033 |
| 49 | FER | 1.20176972 |
| 50 | TAOK2 | 1.19723587 |
| 51 | STK4 | 1.19645328 |
| 52 | FGFR4 | 1.19545992 |
| 53 | CDC42BPA | 1.18754738 |
| 54 | CDK6 | 1.17608441 |
| 55 | CLK1 | 1.14473163 |
| 56 | FLT3 | 1.13719944 |
| 57 | FRK | 1.13620017 |
| 58 | MAP3K2 | 1.12571029 |
| 59 | CSF1R | 1.12126542 |
| 60 | MST4 | 1.12004155 |
| 61 | MAP3K10 | 1.09424806 |
| 62 | LMTK2 | 1.08218052 |
| 63 | MUSK | 1.08072415 |
| 64 | GRK7 | 1.07327970 |
| 65 | STK3 | 1.06979408 |
| 66 | CDK12 | 1.05748945 |
| 67 | ABL2 | 1.04230076 |
| 68 | CSK | 1.03501260 |
| 69 | ERBB3 | 0.98409907 |
| 70 | EPHB1 | 0.96715981 |
| 71 | MAPKAPK3 | 0.95956152 |
| 72 | TGFBR1 | 0.95096325 |
| 73 | MELK | 0.94334361 |
| 74 | NLK | 0.94263309 |
| 75 | LATS2 | 0.93834953 |
| 76 | PTK6 | 0.93448446 |
| 77 | ITK | 0.93419639 |
| 78 | TESK1 | 0.91217753 |
| 79 | MAP3K9 | 0.91073621 |
| 80 | MOS | 0.90917923 |
| 81 | LIMK1 | 0.90779080 |
| 82 | SMG1 | 0.89709285 |
| 83 | KDR | 0.89114339 |
| 84 | MYLK | 0.88929932 |
| 85 | RIPK1 | 0.85345731 |
| 86 | STK38 | 0.83281058 |
| 87 | RPS6KB2 | 0.82771600 |
| 88 | PAK4 | 0.81231675 |
| 89 | HCK | 0.80300578 |
| 90 | MAP3K1 | 0.76859802 |
| 91 | EIF2AK2 | 0.71834421 |
| 92 | BMX | 0.71644872 |
| 93 | RPS6KA6 | 0.71183458 |
| 94 | GRK6 | 0.70020097 |
| 95 | JAK2 | 0.69702228 |
| 96 | AKT3 | 0.69173537 |
| 97 | RPS6KC1 | 0.66265094 |
| 98 | RPS6KL1 | 0.66265094 |
| 99 | LCK | 0.65989802 |
| 100 | EIF2AK1 | 0.65801143 |
| 101 | CAMK1D | 0.65727224 |
| 102 | SYK | 0.65063808 |
| 103 | MAPKAPK2 | 0.64687015 |
| 104 | CDK4 | 0.63498766 |
| 105 | PIK3CA | 0.63492031 |
| 106 | LATS1 | 0.62740875 |
| 107 | LYN | 0.60256139 |
| 108 | EPHB2 | 0.59750781 |
| 109 | EPHA2 | 0.59212126 |
| 110 | GRK1 | 0.56073013 |
| 111 | HIPK2 | 0.56032793 |
| 112 | MST1R | 0.55766129 |
| 113 | BCKDK | 0.55057120 |
| 114 | ILK | 0.53981335 |
| 115 | PDGFRB | 0.53182687 |
| 116 | MAP3K8 | 0.52996409 |
| 117 | MATK | 0.51945487 |
| 118 | RIPK4 | 0.51625350 |
| 119 | MARK3 | 0.51520950 |
| 120 | NUAK1 | 0.51419311 |
| 121 | MAP2K1 | 0.50476797 |
| 122 | PIK3CG | 0.48758193 |
| 123 | IRAK1 | 0.48587060 |
| 124 | TAOK3 | 0.47188679 |
| 125 | PDGFRA | 0.46024925 |
| 126 | MAPK7 | 0.45626456 |
| 127 | TIE1 | 0.44944550 |
| 128 | CDK9 | 0.43930383 |
| 129 | PRKCI | 0.43915946 |
| 130 | ADRBK2 | 0.42815502 |
| 131 | PLK4 | 0.41986041 |
| 132 | PDK2 | 0.41035734 |
| 133 | ABL1 | 0.40793906 |
| 134 | PDPK1 | 0.39807591 |
| 135 | GSK3A | 0.39804287 |
| 136 | PRKG2 | 0.39759450 |
| 137 | PRKD1 | 0.39431507 |
| 138 | PAK2 | 0.38674255 |
| 139 | MAPK11 | 0.38546874 |
| 140 | CDK7 | 0.38427185 |
| 141 | EIF2AK3 | 0.38094079 |
| 142 | ACVR1B | 0.36691975 |
| 143 | MAP3K11 | 0.36630370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.87282594 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46644327 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.32562304 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02365886 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87945739 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82665264 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82394462 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 1.82110543 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.75832908 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74060654 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68219197 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63092197 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62372656 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.57100606 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53607040 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.46553242 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44534129 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41687949 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39386205 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36448825 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35086346 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34138860 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33986495 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33614628 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33599646 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33552444 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.32001888 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30320602 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29185432 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28603958 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.26715329 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26529882 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20616732 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20284998 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20142002 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.17723026 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17308509 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17264165 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.15718312 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15682047 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14751445 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12937836 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.10586186 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09223775 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08658319 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.07864696 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.07116810 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 1.06208576 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05700768 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.05662197 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.05659282 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05496535 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04979339 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04791015 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03374967 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 1.01232091 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.99409220 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.99394175 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.99057224 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.96839761 |
| 61 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.92282970 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91231833 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89926409 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87908996 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86717369 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85255010 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.84927356 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84064669 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83616662 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83310563 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80338631 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78215156 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.78005612 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77238002 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.76074952 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.75922201 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.75879627 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75734451 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71280863 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70287628 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69569485 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.69145921 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68733009 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65018810 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64583399 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64389887 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64388647 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64337092 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.64044476 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63207900 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62549308 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62209753 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61176550 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60929212 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60919294 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60398279 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60147605 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.58274584 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57193138 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56816596 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55851978 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53961693 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53621155 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53469258 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53318723 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53286792 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52457119 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52451578 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51644071 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.51538358 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51017626 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.49949634 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48934353 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48755211 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48703362 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48308435 |
| 117 | Melanoma_Homo sapiens_hsa05218 | 0.47556303 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47533403 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47181568 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46139032 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43377624 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41927510 |

